Legal Representation
Attorney
Christopher A. Sidoti
USPTO Deadlines
Application History
6 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 3, 2006 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 3, 2006 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Feb 20, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 20, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 20, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Analgesic preparations
First Use Anywhere:
Oct 27, 2004
First Use in Commerce:
Oct 27, 2004
Additional Information
Design Mark
The mark consists of the top part of a stethoscope in the shape of a heart around a tablet with a pie shape piece missing and the outside of the tablet is the color orange; the words #1 CARDIOLOGIST RECOMMENDED ASPIRIN is across the middle of stethoscope; color is claimed as a feature of the mark..
Color Claim
The color(s) Orange is/are claimed as a feature of the mark.
Pseudo Mark
NUMBER ONE CARDIOLOGIST RECOMMENDED ASPIRIN
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"#1 CARDIOLOGIST RECOMMENDED ASPIRIN"